NEW YORK (GenomeWeb News) — Correlogic Systems has signed a research and development agreement with a Japanese mass-spec maker to enhance clinical mass spectrometry, Correlogic said today.
 
Correlogic and Tokyo-based JEOL, which also makes nuclear magnetic resonance instruments and electron optical equipment, have been involved in an “informal” research collaboration for more than a year, Correlogic said. The firm said they have “made great strides in the continuing validation of various mass spectrometer-based assays.”

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.